MedTrace Logo

Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)

NCT01221129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2011-09-20

No results posted yet for this study

Summary

The specific aim of this protocol is to examine differential expression of specific mRNAs and proteins that occur when the dietary intake of zinc is acutely reduced below the dietary requirement for a period of ten days.

Conditions

  • Zinc Deficiency

Interventions

OTHER

Acclimation

11 mg Zn/day as a controlled intake level

OTHER

Dietary zinc depletion

\< 1 mg Zn/day achieved by providing a liquified diet of defined nutrient content

OTHER

Dietary zinc repletion

15 mg Zn/day as a daily supplement plus normal habitual diet without restriction

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Robert J Cousins, Ph.D. · University of Florida

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221129 on ClinicalTrials.gov